Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,064 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design, Synthesis, and Monoamine Oxidase B Selective Inhibitory Activity of N-Arylated Heliamine Analogues.
Yamada M, Hirose Y, Lin B, Fumimoto M, Nunomura K, Natchanun S, Takahashi N, Ohki Y, Sako M, Murai K, Harada K, Arai M, Suzuki S, Nakamura T, Haruta J, Arisawa M. Yamada M, et al. Among authors: suzuki s. ACS Med Chem Lett. 2022 Aug 22;13(10):1582-1590. doi: 10.1021/acsmedchemlett.2c00228. eCollection 2022 Oct 13. ACS Med Chem Lett. 2022. PMID: 36262392 Free PMC article.
Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia.
Sakurai M, Kikuchi T, Karigane D, Kasahara H, Matsuki E, Hashida R, Yamane Y, Abe R, Koda Y, Toyama T, Kato J, Shimizu T, Yokoyama Y, Suzuki S, Nakamura T, Okamoto S, Mori T. Sakurai M, et al. Among authors: suzuki s. Int J Hematol. 2019 Mar;109(3):292-298. doi: 10.1007/s12185-019-02596-z. Epub 2019 Jan 24. Int J Hematol. 2019. PMID: 30680668 Clinical Trial.
Prognostic Value of Baseline Medications Plus Neutrophil-to-Lymphocyte Ratio in the Effectiveness of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer: A Retrospective Study.
Ogiwara T, Kawazoe H, Egami S, Hashimoto H, Saito Y, Sakiyama N, Ohe Y, Yamaguchi M, Furukawa T, Hara A, Hiraga Y, Jibiki A, Yokoyama Y, Suzuki S, Nakamura T. Ogiwara T, et al. Among authors: suzuki s. Front Oncol. 2021 Nov 8;11:770268. doi: 10.3389/fonc.2021.770268. eCollection 2021. Front Oncol. 2021. PMID: 34820333 Free PMC article.
Development and validation of a new liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of afatinib, dacomitinib, osimertinib, and the active metabolites of osimertinib in human serum.
Ishikawa E, Yokoyama Y, Chishima H, Kuniyoshi O, Sato I, Nakaya N, Nakajima H, Kimura M, Hakamata J, Suehiro N, Nakada H, Ikemura S, Jibiki A, Kawazoe H, Muramatsu H, Suzuki S, Nakamura T. Ishikawa E, et al. Among authors: suzuki s. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 May 30;1199:123245. doi: 10.1016/j.jchromb.2022.123245. Epub 2022 Apr 4. J Chromatogr B Analyt Technol Biomed Life Sci. 2022. PMID: 35436724 Free article.
Simultaneous quantification of dasatinib, nilotinib, bosutinib, and ponatinib using high-performance liquid chromatography-Photodiode array detection.
Yokoyama Y, Nozawa E, Morita M, Ishikawa E, Mori T, Sakurai M, Kikuchi T, Matsuki E, Yamazaki R, Kataoka K, Jibiki A, Kawazoe H, Suzuki S, Nakamura T. Yokoyama Y, et al. Among authors: suzuki s. J Clin Lab Anal. 2022 Aug;36(8):e24598. doi: 10.1002/jcla.24598. Epub 2022 Jul 12. J Clin Lab Anal. 2022. PMID: 35819095 Free PMC article.
14,064 results
You have reached the last available page of results. Please see the User Guide for more information.